Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UKALL 2011 trial for children and young adults with acute lymphoblastic leukaemia and lymphoblastic lymphoma
2010-020924-22Phase 3Unknown
- Sponsor
- University of Birmingham
- Start
- Sep 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexamethasone, methotrexate and vincristine in acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LL) (6 arms), sponsored by University of Birmingham. Primary endpoint: Induction steroid-induced morbidity. Status: unknown.
02
Drugs
dexamethasonemethotrexatevincristine
03
Conditions
acute lymphoblastic leukemia (ALL)lymphoblastic lymphoma (LL)
Beyond the preview
Go deeper on 2010-020924-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020924-22.